PATH
Seattle, Washington, United States
Purpose
To transfer technology and to develop the manufacturing processes for the P2-VP8 trivalent non-replicating rotavirus vaccine at SK Chemicals, Seoul, South Korea; a potential vaccine against severe rotavirus disease in infants
Division
Global Health
Date
January 2017
Region Served
GLOBAL
Committed amount
$9,109,636
Grant topic
Enterics, Diagnostics, Genomics & Epidemiology
Duration (months)
101
Grantee location
Seattle, Washington, United States
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.